DE1470260C - 3,5 Dioxopyrazoiidine derivatives and a process for their preparation - Google Patents
3,5 Dioxopyrazoiidine derivatives and a process for their preparationInfo
- Publication number
- DE1470260C DE1470260C DE1470260C DE 1470260 C DE1470260 C DE 1470260C DE 1470260 C DE1470260 C DE 1470260C
- Authority
- DE
- Germany
- Prior art keywords
- solution
- sodium
- diphenyl
- absolute methanol
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims 2
- 238000002360 preparation method Methods 0.000 title claims 2
- 239000011541 reaction mixture Substances 0.000 claims description 11
- -1 1,2-diphenyl-3,5-dioxopyrazolidine sodium Chemical compound 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N Dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 6
- XDPKQGKEOCYMQC-UHFFFAOYSA-N 1,2-diphenylpyrazolidine-3,5-dione Chemical compound O=C1CC(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 XDPKQGKEOCYMQC-UHFFFAOYSA-N 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000005842 heteroatoms Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims description 2
- DNTVKOMHCDKATN-UHFFFAOYSA-N pyrazolidine-3,5-dione Chemical class O=C1CC(=O)NN1 DNTVKOMHCDKATN-UHFFFAOYSA-N 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 12
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 7
- 229910052708 sodium Inorganic materials 0.000 claims 7
- 239000011734 sodium Substances 0.000 claims 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 239000000706 filtrate Substances 0.000 claims 6
- 239000000047 product Substances 0.000 claims 5
- ZYZWOSIRFVIBRH-UHFFFAOYSA-N chloroform;cyclohexane Chemical compound ClC(Cl)Cl.C1CCCCC1 ZYZWOSIRFVIBRH-UHFFFAOYSA-N 0.000 claims 4
- 238000001816 cooling Methods 0.000 claims 4
- 238000001953 recrystallisation Methods 0.000 claims 4
- 238000003756 stirring Methods 0.000 claims 4
- 239000003610 charcoal Substances 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 3
- 239000000155 melt Substances 0.000 claims 3
- QDHLEFBSGUGHCL-UHFFFAOYSA-N 2-[(dimethylamino)methyl]cyclohexan-1-one Chemical compound CN(C)CC1CCCCC1=O QDHLEFBSGUGHCL-UHFFFAOYSA-N 0.000 claims 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- 239000012043 crude product Substances 0.000 claims 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims 2
- APOWZIQNQJSLKG-UHFFFAOYSA-N 2-(dimethylamino)-1-phenylpropan-1-one;hydron;chloride Chemical compound Cl.CN(C)C(C)C(=O)C1=CC=CC=C1 APOWZIQNQJSLKG-UHFFFAOYSA-N 0.000 claims 1
- AZNXLTZGEVCWAA-UHFFFAOYSA-N 4-[3-(4-chlorophenyl)-3-oxopropyl]-1,2-diphenylpyrazolidine-3,5-dione Chemical compound C1=CC(Cl)=CC=C1C(=O)CCC1C(=O)N(C=2C=CC=CC=2)N(C=2C=CC=CC=2)C1=O AZNXLTZGEVCWAA-UHFFFAOYSA-N 0.000 claims 1
- CQVCTHJIJAUHMD-UHFFFAOYSA-N Cl.OC1=C(C=CC=C1)C(C(C)N(C)C)=O Chemical compound Cl.OC1=C(C=CC=C1)C(C(C)N(C)C)=O CQVCTHJIJAUHMD-UHFFFAOYSA-N 0.000 claims 1
- OQRXLROWARENMC-UHFFFAOYSA-N N1NCCC1.[Na] Chemical compound N1NCCC1.[Na] OQRXLROWARENMC-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 description 9
- 241000700159 Rattus Species 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 208000008423 Pleurisy Diseases 0.000 description 3
- 230000001476 alcoholic Effects 0.000 description 3
- 210000000416 Exudates and Transudates Anatomy 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 230000003110 anti-inflammatory Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical group 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000001760 anti-analgesic Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 150000003218 pyrazolidines Chemical class 0.000 description 1
- 231100000730 tolerability Toxicity 0.000 description 1
Description
Die Erfindung betrifft 3,5-Dioxopyrazolidinderivate der allgemeinen Formel ■ ■■ ■ The invention relates to 3,5-dioxopyrazolidine derivatives of the general formula ■ ■■ ■
R-H2C- HCRH 2 C- HC
CO — N — QH5 CO - N - QH 5
-N-QH5 -N-QH 5
worin R eine gegebenenfalls in o-Stellung durch eine Hydroxygruppe oder in p-Stellung durch ein Chloratom substituierte 2-Phenyl-2-oxoäthylgruppe oder eine 2-Oxo-cyclohexylgruppe bedeutet. .wherein R is optionally in the o-position by a Hydroxy group or 2-phenyl-2-oxoethyl group substituted in the p-position by a chlorine atom or means a 2-oxo-cyclohexyl group. .
Diese Verbindungen besitzen entzündungshemmende und analgetische Wirkung und zeichnen sich im Vergleich zu bekannten 4-Alkyl-l,2-diphenyl-3,5-dioxopyrazolidinen durch wesentlich niedrigere Tpxizität und bessere Verträglichkeit aus.These compounds have anti-inflammatory and analgesic effects and stand out compared to known 4-alkyl-1,2-diphenyl-3,5-dioxopyrazolidines characterized by a significantly lower habit and better tolerability.
Die erfindungsgemäßen Substanzen wurden hinsichtlich ihrer entzündungshemmenden Wirksamkeit mit den bekannten Substanzen 1,2-Diphenyl-3,5-dioxo-4-n-butyl-pyrazolidin (A) und 1 ^-DiphenyW^-dioxo-4-(3'-oxobutyl)-pyrazolidin (B) verglichen. In der folgenden Tabelle sind die akute Toxizität bei peroraler Verabreichung an Ratten (LD50), die prozentuale Inhibition des Exsudats bei der experimentellen Brustfellentzündung (Pleuritis) bei peroraler Verabreichung einer Dosis von 200 mg/kg Ratte, die daraus berechnete ED50 in mg/kg und die therapeutische Breite LD50ZED50 angegeben.The substances according to the invention were compared with the known substances 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (A) and 1 ^ -DiphenyW ^ -dioxo-4- (3'-oxobutyl) with regard to their anti-inflammatory activity ) -pyrazolidine (B) compared. The following table shows the acute toxicity after oral administration to rats (LD 50 ), the percentage inhibition of exudate in experimental pleurisy (pleurisy) after oral administration of a dose of 200 mg / kg rat, the calculated ED 50 in mg / kg and the therapeutic range LD 50 ZED 50 are given.
Aus der Tabelle ergibt sich, daß die therapeutische Breite aller erfindungsgemäßen Substanzen besser ist als die der bekannten Substanzen; die beste therapeutische Breite weist die nach Beispiel 1 erhältliche Verbindung auf.The table shows that the therapeutic range of all substances according to the invention is better than that of known substances; that obtainable according to Example 1 shows the best therapeutic range Connection on.
mg/kg Ratteacute toxicity
mg / kg rat
ED50 mg/kgEffective dose
ED 50 mg / kg
exp. Pleuritis RatteExudate at the
exp. Pleurisy rat
Die Verbindungen der allgemeinen Formel I werden dadurch hergestellt, daß man in an sich bekannter Weise l,2-Diphenyl-3,5-dioxopyrazolidin der FormelThe compounds of general formula I are prepared by being known per se Way 1,2-diphenyl-3,5-dioxopyrazolidine of the formula
/CO-N-QH5 H2C/ CO-N-QH 5 H 2 C
\:O —N-QH5 .\: O-N-QH 5 .
mit einer Verbindung der allgemeinen Formelwith a compound of the general formula
IIII
R-CH2-N-R2 R-CH 2 -NR 2
ΧΘ Χ Θ
IIIIII
worin Rx und R2 Alkylreste mit 1 bis 4 Kohlenstoffatomen, Welche mit dem Stickstoffatom einen gegebenenfalls noch weitere Heteroatome tragenden heterocyclischen Ring bilden können, R3 einen Alkylrest mit 1 bis 4 Kohlenstoffatomen oder einen Aralkylrest und Xe ein Anion einer anorganischen Säure bedeutet, in Gegenwart einer Lösung eines Alkalimetallalkoholate in einem absoluten Alkanol mit 1 bis 4 Kohlenstoffatomen bei Siedetemperatur des Reaktionsgemisches umsetzt.where R x and R 2 are alkyl radicals with 1 to 4 carbon atoms, which with the nitrogen atom can form a heterocyclic ring optionally bearing further heteroatoms, R 3 is an alkyl radical with 1 to 4 carbon atoms or an aralkyl radical and X e is an anion of an inorganic acid, in the presence of a solution of an alkali metal alcoholate in an absolute alkanol having 1 to 4 carbon atoms at the boiling point of the reaction mixture.
Zur Herstellung der Ausgangsstoffe der allgemeinen Formel III stellt man aus einem entsprechenden Keton die Mannichbase der allgemeinen FormelThe starting materials of the general formula III are prepared from a corresponding ketone the Mannich base of the general formula
R — CH, — NR - CH, - N
her, die man z. B. mit Hilfe von einem Alkylhalogcnid oder Dialkylsulfat, insbesondere Methyljodid oder Dimethylsulfat, zur Verbindung der allgemeinen Formel III quaternisiert.here that one z. B. with the help of an alkyl halide or dialkyl sulfate, in particular methyl iodide or dimethyl sulfate, for the compound of the general formula III quaternized.
Zur" Durchführung des erfindungsgemäßen Verfahrens vermischt man bei Zimmertemperatur eine Lösung eines Alkalisalzes des l,2-Diphenyl-3,5-dioxo-.To "carry out the method according to the invention if mixed at room temperature, a solution of an alkali salt of 1,2-diphenyl-3,5-dioxo-.
pyrazolidins der Formel II mit dem frisch hergestellten quaternären Salz der allgemeinen Formel III und beendigt die Reaktion durch mehrstündiges Kochen der Reaktionsmischung unter Rückfluß. Das Reaktionsprodukt wird dann in üblicher Weise, z. B. durch Eindampfen der Reaktionsmischung zur Trockne, Extraktion des Rückstandes mit einer wäßrigen Alkalimetallhydroxylösung und Ansäuern dieses Extraktes isoliert. ,pyrazolidines of the formula II with the freshly prepared quaternary salt of the general formula III and terminates the reaction by refluxing the reaction mixture for several hours. The reaction product is then in the usual way, for. B. by evaporating the reaction mixture to dryness, Extraction of the residue with an aqueous alkali metal hydroxyl solution and acidifying this extract isolated. ,
Man kann auch den Ausgangsstoff der allgemeinen Formel HI erst in der Reaktionsmischung herstellen. Hierbei stellt man zunächst in einer alkoholischen Alkalimetallalkoholatlösung aus einem geeigneten Salz die freie Mannichbase der allgemeinen FormelIt is also possible to prepare the starting material of the general formula HI only in the reaction mixture. In this case, a suitable alkali metal alcoholate solution is first prepared from an alcoholic alkali metal alcoholate solution Salt the Mannich free base of the general formula
IV R-CH2-NIV R-CH 2 -N
her, setzt eine alkoholische Lösung eines Alkalisalzes des l,2-Diphenyl-3,5-dioxo'pyrazoIidins der Formel II zu, erwärmt die Reaktionsmischung zum Sieden, worauf man die siedende Mischung mit einer alkoholischen Lösung des quaternisierenden Mittels, z. B. Dimethylsulfat, versetzt. Die Reaktion wird durch mehrstündiges Kochen unter Rückfluß beendigt. Das Reaktionsprodukt wird dann wie oben angegeben isoliert.her, uses an alcoholic solution of an alkali salt of 1,2-diphenyl-3,5-dioxo'pyrazoIidins of the formula II to, the reaction mixture is heated to the boil, whereupon the boiling mixture is mixed with an alcoholic Solution of the quaternizing agent, e.g. B. dimethyl sulfate, added. The reaction will go through several hours of refluxing ended. The reaction product is then given as above isolated.
Claims (2)
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1645971B2 (en) | (Indazol-3-y l) -oxyacetic acid derivatives, process for their preparation and agents with anti-inflammatory effects | |
DE1643296A1 (en) | Means for the treatment of bronchospastic symptoms | |
EP0883610B1 (en) | Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives | |
EP0018360B1 (en) | N-(5-methoxybenzofuran-2-ylcarbonyl)-n'-benzylpiperazine and process for its preparation | |
DE2634336C3 (en) | Diaminoandrostane derivatives, their acid addition salts and quaternary salts and a process for the preparation of these compounds | |
DE1470260C (en) | 3,5 Dioxopyrazoiidine derivatives and a process for their preparation | |
DE2438413A1 (en) | HETEROCYCLIC COMPOUNDS AND METHOD FOR MAKING THE SAME | |
DE2336670A1 (en) | AMINO ETHERS OF O-THYMOTIC ACID ESTERS | |
DE2166270C3 (en) | Nicotinoylaminoethanesulfonyl-2amino-thiazole | |
DE2536170C3 (en) | Flavone derivatives, processes for their preparation and pharmaceuticals containing these compounds | |
DE1470260B (en) | 3,5-Dioxopyrazolidine derivatives and a process for their preparation | |
CH643831A5 (en) | CINNAMYL MORANOLINE DERIVATIVES. | |
DE3104785A1 (en) | BASIC ETHERS OF 4-HYDROXY-BENZOPHENONE, WHICH ARE EFFECTIVE AS (BETA) BLOCKERS, AND METHOD FOR THE PRODUCTION THEREOF | |
DE1101428B (en) | Process for the preparation of long-acting aminobenzenesulfonic acid amide derivatives | |
DE2210121C3 (en) | Pyrido square bracket to 2,3-square bracket to indole, a process for their preparation and medicinal products containing these compounds | |
DE1007335B (en) | Process for the preparation of new chlorinated benzoic acid alcohol esters | |
AT251580B (en) | Process for the preparation of new piperidine carboxylic acid esters | |
AT226710B (en) | Process for the preparation of new dihydroquinoxalones (2) and their salts | |
AT226706B (en) | Process for the preparation of new derivatives of nicotinic acid | |
AT222116B (en) | Process for the preparation of new, 4-substituted 1,2-diaryl-3,5-dioxo-pyrazolidines | |
AT230372B (en) | Process for the preparation of new 4-amino-1-phenyl-2,3-dimethyl-pyrazolone derivatives | |
DE1445059A1 (en) | Process for the preparation of new pharmacologically valuable carbostyril derivatives | |
AT213864B (en) | Process for the preparation of new analgesic α-amino-β-oxybutyric acid amides | |
AT282593B (en) | PROCESS FOR THE PREPARATION OF NEW RACEMIC OR OPTICALLY ACTIVE (1-2'-NITRILOPHENOXY) -2-HYDROXY-3-ISOPROPYLAMINOPROPANE AND ITS SALTS | |
AT165073B (en) | Process for the preparation of substituted piperido-octahydrophenanthrenes |